Search Within

Alan Loh Ho

Formats
  1. Journal Article (111)
  2. Meeting Abstract (104)
  3. Review (7)
  4. Editorial (4)
  5. Guidelines (4)
  6. Research Letter (4)
  7. Book Section (2)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (237)
  2. Head and Neck Service (237)
  3. Solid Tumor Oncology Division (237)
  4. Department of Pathology and Laboratory Medicine (93)
  5. Surgery (78)
  6. GSK Faculty (69)

More Groups

People
  1. David Pfister (89)
  2. Eric Sherman (84)
  3. Lara Dunn (53)
  4. Nora Katabi (48)
  5. Nancy Lee (42)
  6. Sofia Haque (40)

More People

Years
  1. 2025 (5)
  2. 2024 (25)
  3. 2023 (26)
  4. 2022 (23)
  5. 2021 (18)
  6. 2020 (21)

More Years

Publications
  1. Journal of Clinical Oncology (73)
  2. Annals of Oncology (20)
  3. International Journal of Radiation Oncology, Biology, Physics (14)
  4. Cancer Research (10)
  5. Clinical Cancer Research (8)
  6. Journal of the National Comprehensive Cancer Network (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (75)
  2. Elsevier Inc. (27)
  3. Oxford University Press (24)
  4. American Association for Cancer Research (23)
  5. Springer (11)
  6. Wiley Blackwell (11)

More Publishers

Results (237)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of trametinib in combination with paclitaxel in the treatment of anaplastic thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Michel, L. S.; Kriplani, A.; Dunn, L.; Haque, S.; Bang, D.; Stein, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 2 study of the oral vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, rivoceranib, for recurrent or metastatic (R/M) adenoid cystic carcinoma (ACC)
    Meeting Abstract

    Kang, H.; Ahn, M. J.; Muzaffar, J.; Keam, B.; Bowles, D. W.; Wong, D. J. L.; Ho, A. L.; Kim, S. B.; Worden, F. P.; Yun, T.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1/2 trial to evaluate the safety and antitumor activity of tipifarnib and alpelisib for patients with PIK3CA-mutated/amplified and/or HRAS-overexpressing recurrent/metastatic head and neck squamous cell carcinoma
    Meeting Abstract

    Hanna, G. J.; Perez, C. A.; Ho, A. L.; Gillison, M. L.; Adkins, D.; Dayoub, A.; Saunders, A.; Leoni, M.; Dale, S.; Nie, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Recommended phase 2 dose (RP2D) of HB-200 arenavirus-based cancer immunotherapies in patients with HPV16+cancers
    Meeting Abstract

    Fu, S.; Nabell, L.; Pearson, A. T.; Leidner, R.; Adkins, D.; Posner, M. R.; Nieva, J. J.; Richardson, D. L.; Pimentel, A.; Goel, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Results of ACCURACY: A phase 2 trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notch(mut))
    Meeting Abstract

    Ferrarotto, R.; Metcalf, R.; Rodriguez, C. P.; Muzaffar, J.; Even, C.; Perez, A.; Van Herpen, C. M. L.; Oliva, M.; Xia, B.; Bowles, D. W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Ho, A. L.; Ganly, I.; Riaz, N.; Morris, L.; Hung, K. W.; Kriplani, A.; Cracchiolo, J. R.; Cohen, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Toxicity profiles and survival outcomes among patients with nonmetastatic oropharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy
    Journal Article

    Youssef, I.; Yoon, J.; Mohamed, N.; Zakeri, K.; Press, R. H.; Chen, L.; Gelblum, D. Y.; McBride, S. M.; Tsai, C. J.; Riaz, N.; more...
    JAMA Network Open (2022)

    Fulltext@MSK | Save
  • Targeting HRAS in head and neck cancer: Lessons from the past and future promise
    Review

    Desilets, A.; Ho, A. L.
    The Cancer Journal (2022)

    Fulltext@MSK | Save
  • Selumetinib plus adjuvant radioactive iodine in patients with high-risk differentiated thyroid cancer: A phase III, randomized, placebo-controlled trial (ASTRA)
    Journal Article

    Ho, A. L.; Dedecjus, M.; Wirth, L. J.; Tuttle, R. M.; Inabnet, W. B. 3rd; Tennvall, J.; Vaisman, F.; Bastholt, L.; Gianoukakis, A. G.; Rodien, P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save